Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: We previously reported gut dysbiosis in patients with Parkinson's disease (PD). OBJECTIVE: The aim of this study is to examine whether gut dysbiosis correlates with the progression of PD. METHODS: We examined changes in gut microbiota and demographic features in 2 years in 36 PD patients. RESULTS: A change of total UPDRS scores in 2 years was predicted by the counts of Bifidobacterium and Atopobium cluster at year 0 with a correlation coefficient of 0.52. Correlation analysis additionally revealed that low counts of Bifidobacterium and Bacteroides fragilis at year 0 were associated with worsening of UPDRS I scores in 2 years. In addition, low counts of Bifidobacterium at year 0 were associated with worsening of hallucinations/delusions in 2 years. Similarly, low counts of B. fragilis at year 0 were associated with worsening of motivation/initiative in 2 years. The patients were evenly divided into the deteriorated and stable groups based on the degree of worsening of total UPDRS scores. The deteriorated group had lower counts of Bifidobacterium, B. fragilis, and Clostridium leptium than the stable group at year 0 but not at year 2, suggesting that the deteriorated group may demonstrate accelerated lowering of these bacteria at year 0. CONCLUSIONS: The total counts of intestinal bacterial decrease in the course of PD progression. Temporal profiles of lowering of bacterial counts are likely to be different from bacteria to bacteria, and also between the deteriorating and stable groups, which may be able to be exploited to differentiate patients with rapidly and slowly progressive PD pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Minato et al. 57 investigated the relationship between intestinal disorders and disease progression through a 2-year follow-up of patients with Parkinson's disease and found that the decreased abundance of Bifidobacterium and Bacteroides fragilis was related to the deterioration of the Unified Parkinson's Disease Rating Scale (UPDRS)-I score”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [57]
The cited source says what the claim attributes to it.
In the citing paper
“suggesting that the gut microbiota may be seriously influenced by disease progression.57”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [57]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
(1996) · Institutional Research Information System University of Turin (University of Turin) · doi:10.1111/j · Cited by 5,486
Overdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,732
The FAB: A frontal assessment battery at bedside
Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000) · Neurology · doi:10.1212/wnl.55.11.1621 · Cited by 3,913
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Atopic Dermatitis: Global Epidemiology and Risk Factors
Nutten, S. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000370220 · Cited by 3,055
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K. M., Holloway, R. G., Kieburtz, K., Marshall, F. J., Ravina, B. M., Schifitto, G., Siderowf, A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000247740.47667.03 · Cited by 2,472
The prevalence of Parkinson's disease: a systematic review and meta-analysis
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Odamaki, T., Kato, K., Sugahara, H., Hashikura, N., Takahashi, S., Xiao, J.-Z., Abe, F., & Osawa, R. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0708-5 · Cited by 1,521
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Colonic bacterial composition in Parkinson's disease
Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281
Unger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.08.019 · Cited by 1,159
Forsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Estes, J. D., Dodiya, H. B., & Keshavarzian, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028032 · Cited by 974
Akbari, E., Asemi, Z., Daneshvar Kakhaki, R., Bahmani, F., Kouchaki, E., Tamtaji, O. R., Hamidi, G. A., & Salami, M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00256 · Cited by 946
The intestinal microflora in allergic Estonian and Swedish 2‐year‐old children
Björkstén, Naaber, Sepp, & Mikelsaar (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00560.x · Cited by 927
Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874
Frequency of Bowel Movements and the Future Risk of Parkinson’s Disease
Abbott, R. D., Petrovitch, H., White, L. R., Masaki, K. H., Tanner, C. M., Curb, J. D., Grandinetti, A., Blanchette, P. L., Popper, J. S., & Ross, G. W. (2001) · Neurology · doi:10.1212/wnl.57.3.456 · Cited by 839
Meta‐analysis of early nonmotor features and risk factors for Parkinson disease
Noyce, A. J., Bestwick, J. P., Silveira‐Moriyama, L., Hawkes, C. H., Giovannoni, G., Lees, A. J., & Schrag, A. (2012) · Annals of Neurology · doi:10.1002/ana.23687 · Cited by 778
Braak, H., Del Tredici, K., Bratzke, H., Hamm-Clement, J., Sandmann-Keil, D., & Rüb, U. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1301-4 · Cited by 708
Malinen, E., Rinttila, T., Kajander, K., Matto, J., Kassinen, A., Krogius, L., Saarela, M., Korpela, R., & Palva, A. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40312.x · Cited by 699
Systematic evaluation of rating scales for impairment and disability in Parkinson's disease
Ramaker, C., Marinus, J., Stiggelbout, A. M., & van Hilten, B. J. (2002) · Movement Disorders · doi:10.1002/mds.10248 · Cited by 666
Bedarf, J. R., Hildebrand, F., Coelho, L. P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., & Wüllner, U. (2017) · Genome Medicine · doi:10.1186/s13073-017-0428-y · Cited by 642
Fujiwara, Y., Suzuki, H., Yasunaga, M., Sugiyama, M., Ijuin, M., Sakuma, N., Inagaki, H., Iwasa, H., Ura, C., Yatomi, N., et al. (2010) · Geriatrics & Gerontology International · doi:10.1111/j.1447-0594.2010.00585.x · Cited by 631
A timeline for Parkinson's disease
Hawkes, C. H., Del Tredici, K., & Braak, H. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.08.007 · Cited by 594
Frontiers in Aging Neuroscience
(2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi · Cited by 566
Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease
Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., Okamoto, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142164 · Cited by 523
Self-citationAnalysis of Gut Microbiota in Patients with Parkinson’s Disease
Petrov, V. A., Saltykova, I. V., Zhukova, I. A., Alifirova, V. M., Zhukova, N. G., Dorofeeva, Y. B., Tyakht, A. V., Kovarsky, B. A., Alekseev, D. G., Kostryukova, E. S., et al. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3700-7 · Cited by 487
Alpha-synuclein in colonic submucosa in early untreated Parkinson’s disease
Shannon, K. M., Keshavarzian, A., Mutlu, E., Dodiya, H. B., Daian, D., Jaglin, J. A., & Kordower, J. H. (2012) · Movement Disorders · doi:10.1002/mds.23838 · Cited by 469
Ancestral Resurrection and Directed Evolution of Fungal Mesozoic Laccases
Agans, R., Gordon, A., Kramer, D. L., Pérez-Burillo, S., Rufián‐Henares, J. Á., & Paliy, O. (2018) · Institutional Repository of the University of Granada (University of Granada) · doi:10.1128/aem · Cited by 457
Sato, J., Kanazawa, A., Ikeda, F., Yoshihara, T., Goto, H., Abe, H., Komiya, K., Kawaguchi, M., Shimizu, T., Ogihara, T., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2817 · Cited by 437
Self-citationLi, W., Wu, X., Hu, X., Wang, T., Liang, S., Duan, Y., Jin, F., & Qin, B. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-9001-4 · Cited by 406
Folate Production by Bifidobacteria as a Potential Probiotic Property
Pompei, A., Cordisco, L., Amaretti, A., Zanoni, S., Matteuzzi, D., & Rossi, M. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01763-06 · Cited by 354
Gut microbiota in Parkinson disease in a northern German cohort
Hopfner, F., Künstner, A., Müller, S. H., Künzel, S., Zeuner, K. E., Margraf, N. G., Deuschl, G., Baines, J. F., & Kuhlenbäumer, G. (2017) · Brain Research · doi:10.1016/j.brainres.2017.04.019 · Cited by 318
Kelly, L. P., Carvey, P. M., Keshavarzian, A., Shannon, K. M., Shaikh, M., Bakay, R. A. E., & Kordower, J. H. (2014) · Movement Disorders · doi:10.1002/mds.25736 · Cited by 308
Mitsuoka, T. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1992.tb02499.x · Cited by 301
Sensitive Quantitative Detection of Commensal Bacteria by rRNA-Targeted Reverse Transcription-PCR
Matsuda, K., Tsuji, H., Asahara, T., Kado, Y., & Nomoto, K. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01224-06 · Cited by 294
Self-citationDiversity in gut bacterial community of school-age children in Asia
Nakayama, J., Watanabe, K., Jiang, J., Matsuda, K., Chao, S.-H., Haryono, P., La-ongkham, O., Sarwoko, M.-A., Sujaya, I. N., Zhao, L., et al. (2015) · Scientific Reports · doi:10.1038/srep08397 · Cited by 286
Self-citationThe microbiome quality control project: baseline study design and future directions
Sinha, R., Abnet, C. C., White, O., Knight, R., & Huttenhower, C. (2015) · Genome Biology · doi:10.1186/s13059-015-0841-8 · Cited by 265
Matsuda, K., Tsuji, H., Asahara, T., Matsumoto, K., Takada, T., & Nomoto, K. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01843-08 · Cited by 258
Self-citationIntestinal microflora of human infants and current trends for its nutritional modulation
Mountzouris, K. C., McCartney, A. L., & Gibson, G. R. (2002) · British Journal of Nutrition · doi:10.1079/bjn2002563 · Cited by 205
Braekhus, A., Laake, K., & Engedal, K. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01804.x · Cited by 185
Ohigashi, S., Sudo, K., Kobayashi, D., Takahashi, O., Takahashi, T., Asahara, T., Nomoto, K., & Onodera, H. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2526-4 · Cited by 180
Self-citationDevelopment of a Smell Identification Test Using a Novel Stick-Type Odor Presentation Kit
Saito, S., Ayabe-Kanamura, S., Takashima, Y., Gotow, N., Naito, N., Nozawa, T., Mise, M., Deguchi, Y., & Kobayakawa, T. (2006) · Chemical Senses · doi:10.1093/chemse/bjj042 · Cited by 170
Olfaction and Parkinson's syndromes: its role in differential diagnosis
Katzenschlager, R., & Lees, A. J. (2004) · Current Opinion in Neurology · doi:10.1097/01.wco.0000137531.76491.c2 · Cited by 157
Ueno, N., Fujiya, M., Segawa, S., Nata, T., Moriichi, K., Tanabe, H., Mizukami, Y., Kobayashi, N., Ito, K., & Kohgo, Y. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21597 · Cited by 128
Goetze, O., Wieczorek, J., Mueller, T. J., Przuntek, H., Schmidt, W. E., & Woitalla, D. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.007 · Cited by 116
Atmosphere Composition Effects on Burlat Cherry Colour During Cold Storage
Remón, S., Ferrer, A., Buesa, P. L., & Oria, R. (2004) · Zaguan (University of Zaragoza Repository) · doi:10.1002/jsfa · Cited by 101
Bifidobacteria and humans: our special friends, from ecological to genomics perspectives
Ventura, M., Turroni, F., Lugli, G. A., & van Sinderen, D. (2014) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.6356 · Cited by 99
Noh, S. Y., Kang, S., Yun, C., & Han, S. H. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.11.014 · Cited by 98
Ding, P. ‐., & Jin, L. J. (2014) · Journal of Periodontal Research · doi:10.1111/jre.12081 · Cited by 86
Hirayama, M., Hakusui, S., Koike, Y., Ito, K., Kato, T., Ikeda, M., Hasegawa, Y., & Takahashi, A. (1995) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(95)00002-f · Cited by 73
Self-citationAnti-inflammaging effects of Lactobacillus brevis OW38 in aged mice
Jeong, J.-J., Kim, K. A., Hwang, Y.-J., Han, M. J., & Kim, D.-H. (2016) · Beneficial Microbes · doi:10.3920/bm2016.0016 · Cited by 67
Sakaguchi, S., Saito, M., Tsuji, H., Asahara, T., Takata, O., Fujimura, J., Nagata, S., Nomoto, K., & Shimizu, T. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01724-09 · Cited by 62
Self-citationHirayama, M., Nakamura, T., Watanabe, H., Uchida, K., Hama, T., Hara, T., Niimi, Y., Ito, M., Ohno, K., & Sobue, G. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.11.004 · Cited by 38
Self-citation(2014) · Institutional Repository University of Antioquia (University of Antioquia) · doi:10.1371/journal.pone
Cited by
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
Maini Rekdal, V., Bess, E. N., Bisanz, J. E., Turnbaugh, P. J., & Balskus, E. P. (2019) · Science · doi:10.1126/science.aau6323 · Cited by 753
Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism
Barichella, M., Severgnini, M., Cilia, R., Cassani, E., Bolliri, C., Caronni, S., Ferri, V., Cancello, R., Ceccarani, C., Faierman, S., et al. (2019) · Movement Disorders · doi:10.1002/mds.27581 · Cited by 393
“Consistently with previous studies (Supplementary Table 1), we observed a decrease in taxa belonging to Firmicutes pylum, such as the Lachnospiraceae family and other genera (eg, Roseburia)(10,13,15,20,21,23) and an increase in Verrucomicrobia,(9,10,13,15,19) Proteobacteria,(10,13,21,23,50) Christensenellaceae,(15,20)…”
ResultInfluentialThe microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic
Tan, A. H., Lim, S. Y., & Lang, A. E. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00681-2 · Cited by 392
Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression
Aho, V. T. E., Pereira, P. A. B., Voutilainen, S., Paulin, L., Pekkonen, E., Auvinen, P., & Scheperjans, F. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.05.064 · Cited by 361
“One previous publication on gutmicrobiota and PD progression, also with a 2-year follow-up period, found that stable and deteriorated patients had similar microbiota at each timepoint, although Bifidobacterium was less abundant in deteriorated patients at baseline [17].”
BackgroundMethodResultInfluential
Metadata
- Authors
- Minato, T., Maeda, T., Fujisawa, Y., Tsuji, H., Nomoto, K., Ohno, K., & Hirayama, M.
- Affiliations
- Nagoya University (JP)
- Iwate Medical University (JP)
- Yakult Central Institute (JP)
- Corresponding author
- Ohno, Kinji
- Hirayama, Masaaki
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-11-01
- Volume
- 12
- Issue
- 11
- Pages
- e0187307
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5665539
- OpenAlex
- W2766355490
- Cited by
- 248
- References
- 54
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 27 · 2023: 29 · 2022: 40 · 2021: 42 · 2020: 37 · 2019: 33 · 2018: 19 · 2017: 1
- FWCI
- 17.13
- Type
- journal article
- Language
- en
- Update notices
- expression_of_concern (2023-01-11)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Japan Society for the Promotion of Science (JP) (24500458, 15H04840)
- Japan Agency for Medical Research and Development (JP) (17gm1010002h0002)
- Smoking Research Foundation (JP)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Parkinson's disease, gut dysbiosis, gut microbiota, disease progression, Unified Parkinson's Disease Rating Scale, Bifidobacterium, Bacteroides fragilis, Atopobium, delusions and hallucinations, motor symptoms, disease progression biomarkers
- MeSH terms
- Gastrointestinal Microbiome, Aged, Bacteroides fragilis, Bifidobacterium, Clostridium, Female, Follow-Up Studies, Humans, Male, Middle Aged, Parkinson Disease, Colony Count, Microbial, Disease Progression, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.